These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34739737)

  • 1. Controlled In-Cell Generation of Active Palladium(0) Species for Bioorthogonal Decaging.
    Konč J; Sabatino V; Jiménez-Moreno E; Latocheski E; Pérez LR; Day J; Domingos JB; Bernardes GJL
    Angew Chem Int Ed Engl; 2022 Feb; 61(8):e202113519. PubMed ID: 34739737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding Transition Metal-Mediated Bioorthogonal Decaging to Include C-C Bond Cleavage Reactions.
    Dal Forno GM; Latocheski E; Beatriz Machado A; Becher J; Dunsmore L; St John AL; Oliveira BL; Navo CD; Jiménez-Osés G; Fior R; Domingos JB; Bernardes GJL
    J Am Chem Soc; 2023 May; 145(19):10790-10799. PubMed ID: 37133984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Utilization of Black Phosphorus Nanosheets to Enhance Palladium-Mediated Bioorthogonal Catalytic Activity for Activation of Therapeutics.
    Rong M; Liu J; Sun Z; Li T; Li Y; Jiang C; Lu L
    Angew Chem Int Ed Engl; 2023 May; 62(19):e202216822. PubMed ID: 36917027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.
    Weiss JT; Dawson JC; Fraser C; Rybski W; Torres-Sánchez C; Bradley M; Patton EE; Carragher NO; Unciti-Broceta A
    J Med Chem; 2014 Jun; 57(12):5395-404. PubMed ID: 24867590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioorthogonal nanosystem for imaging and in vivo tumor inhibition.
    Li B; Liu P; Wu H; Xie X; Chen Z; Zeng F; Wu S
    Biomaterials; 2017 Sep; 138():57-68. PubMed ID: 28554008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of polystyrene microspheres and functionalization with Pd(0) nanoparticles to perform bioorthogonal organometallic chemistry in living cells.
    Unciti-Broceta A; Johansson EM; Yusop RM; Sánchez-Martín RM; Bradley M
    Nat Protoc; 2012 May; 7(6):1207-18. PubMed ID: 22653159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental-Computational Synergy for Selective Pd(II)-Catalyzed C-H Activation of Aryl and Alkyl Groups.
    Yang YF; Hong X; Yu JQ; Houk KN
    Acc Chem Res; 2017 Nov; 50(11):2853-2860. PubMed ID: 29115826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of Palladium Nanoparticles with Surface Engineered Metal-Organic Frameworks for Cell-Selective Bioorthogonal Catalysis and Protein Activity Regulation.
    Chen X; Cai W; Liu J; Mao L; Wang M
    ACS Appl Mater Interfaces; 2022 Mar; 14(8):10117-10124. PubMed ID: 35179352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Cell Dual Drug Synthesis by Cancer-Targeting Palladium Catalysts.
    Clavadetscher J; Indrigo E; Chankeshwara SV; Lilienkampf A; Bradley M
    Angew Chem Int Ed Engl; 2017 Jun; 56(24):6864-6868. PubMed ID: 28485835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical remodeling of cell-surface sialic acids through a palladium-triggered bioorthogonal elimination reaction.
    Wang J; Cheng B; Li J; Zhang Z; Hong W; Chen X; Chen PR
    Angew Chem Int Ed Engl; 2015 Apr; 54(18):5364-8. PubMed ID: 25765364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thioether-directed palladium-cleavable linker for targeted bioorthogonal drug decaging.
    Stenton BJ; Oliveira BL; Matos MJ; Sinatra L; Bernardes GJL
    Chem Sci; 2018 May; 9(17):4185-4189. PubMed ID: 29780549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioorthogonal Decaging Reactions for Targeted Drug Activation.
    Davies S; Stenton BJ; Bernardes GJL
    Chimia (Aarau); 2018 Nov; 72(11):771-776. PubMed ID: 30514419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palladium concave nanocrystals with high-index facets accelerate ascorbate oxidation in cancer treatment.
    Chong Y; Dai X; Fang G; Wu R; Zhao L; Ma X; Tian X; Lee S; Zhang C; Chen C; Chai Z; Ge C; Zhou R
    Nat Commun; 2018 Nov; 9(1):4861. PubMed ID: 30451824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of platinum(II) complexes and palladium(II) complexes for selective cleavage of peptides and proteins.
    Milović NM; Dutca LM; Kostić NM
    Inorg Chem; 2003 Jun; 42(13):4036-45. PubMed ID: 12817959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Pd(OAc)
    Shao Q; Wu K; Zhuang Z; Qian S; Yu JQ
    Acc Chem Res; 2020 Apr; 53(4):833-851. PubMed ID: 32227915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The organometallic fluorine chemistry of palladium and rhodium: studies toward aromatic fluorination.
    Grushin VV
    Acc Chem Res; 2010 Jan; 43(1):160-71. PubMed ID: 19788304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palladium(II) complexes, as synthetic peptidases, regioselectively cleave the second peptide bond "upstream" from methionine and histidine side chains.
    Milović NM; Kostić NM
    J Am Chem Soc; 2002 May; 124(17):4759-69. PubMed ID: 11971725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation.
    Miller MA; Mikula H; Luthria G; Li R; Kronister S; Prytyskach M; Kohler RH; Mitchison T; Weissleder R
    ACS Nano; 2018 Dec; 12(12):12814-12826. PubMed ID: 30550257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bimetallic redox synergy in oxidative palladium catalysis.
    Powers DC; Ritter T
    Acc Chem Res; 2012 Jun; 45(6):840-50. PubMed ID: 22029861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Homeopathic" palladium nanoparticle catalysis of cross carbon-carbon coupling reactions.
    Deraedt C; Astruc D
    Acc Chem Res; 2014 Feb; 47(2):494-503. PubMed ID: 24215156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.